Sennett R, B Jama, B Hinds, D Tzachanis, GP Morris, and AF Marsch. 2020. Local immune cell infiltration in cutaneous acute graft versus host disease: a prospective cohort study. Intl J Women Dermatol. Doi: 10.1016/j/ijwd.2020.05.009.

Kim PJ, FJ Contijoch, GP Morris, D Wong, and PK Nguyen. 2020. Evaluation of myocardial perfusion and immune cell response in cardiac allograft dysfunction of heart-transplant patients. MedRxiv. Doi: 10.1101/2020.01.28.20018168.

Elkind J, J Sobczyk, O Ostberg-Braun, J Enciso, E Adler, and GP Morris. 2020. Transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. Clin. Transplant. 34:e13772.


Trovillon EM, NJ Gloude, EJ Anderson, and GP Morris. 2019. Relationship of post-transplant thymopoiesis with CD4+FoxP3+ regulatory T cell recovery associated with freedom from chronic graft versus host disease. Bone Marrow Transplant. 54:917-920.

Creary LE, S Guerra, W Chong, C Brown, TR Turner, J Robinson, SGE Marsh, K Saito, J Duke, D Ferriola, D Monos, A Willis, M Askar, G Fischer, CL Saw, I Ragoussis, M Petrek, C Serra-Pages, MJ Otero, C Stavropoulos-Giokas, A Dinou, R Ameen, E Spierings, K Gendzekhadze, D Senitzer, GP Morris, Q Zhang, Z Kashi, S Hsu, S Gangavarapu, CJ Chang, JA Hansen, and MA Fernandez-Vina. 2019. Next-generation HLA typing of 383 International Histocompatibility Working Group B-lymphoblastoid reference cell lines: report from the 17th IHIWS. Human Immunol. 80:449-460.

Osoegawa K, T Vayntrub, S Wenda, D DeSantis, L Creary, K Mallempati, F Yamamoto, K Barsakis, M Ivanova, S Hsu, J Barone, R Holdsworth, M Diviney, M Askar, A Willis, D Railton, S Laflin, K Gendzekhadze, A Oki, N Sacchi, M Mazzocco, M Andreani, R Ameen, C Stavropoulos-Giokas, A Dinou, M Torres, R dos Santos Francisco, C Serra-Pages, A Lindell, S Balladares, M Bettinotti, B Inglehart, Z Kashi, R Martin, CL Saw, I Ragoussis, J Downing, C Navarette, W Chong, Y Saito, M Petrek, S Tokic, K Padros, MB Rodriguez, V Zakharova, O Shragina, S Marino, N Brown, T Shiina, S Suzuki, E Spierings, Q Zhang, GP Morris, A Hernandez, K Seik-Soon, K Tokunaga, R Thomas, A Geretz, U Kanga, S Tyagi, S Marsh, X Liu, D Cao, M Penning, C Hurley, A Cesbron, C Mueller, J Mytilineos, E Weimer, M Bengtsson, G Fischer, SJ Mack, and MA Fernandez-Vina. 2019. Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop. Human Immunol. 80:228-236.


Allen ES, B Yang, J Garrett, ED Ball, M Maiers, and GP Morris. 2018. Improvement of clinical HLA genotyping for hematopoietic stem cell transplantation by next-generation DNA sequencing. Human Immunol. 79:848-854.

Balakrishnan A, B Jama, and GP Morris. 2018. Endogenous co-expression of 2 T cell receptors promotes lymphopenia-induced proliferation via increased affinity for self-antigen. J Leukocyte Biol. 104:1097-1104.


Balakrishnan A, NJ Gloude, B Jama, R Sasik, EJ Anderson, ED Ball, and GP Morris. 2017. Pro-inflammatory dual receptor T cells in chronic graft versus host disease. Biol. Blood Marrow Transplant. 23:1852-1860.

Jani V, E Ingulli, K Mekeel, and GP Morris. 2017 Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients. Human Immunol. 78:72-79.

Morris GP. 2017. Anti-HLA antibodies in lung transplantation. OBM Transplant.1:10.21926.


Balakrishnan A and GP Morris. 2016. The highly alloreactive nature of dual TCR T cells. Curr. Opin. Organ Transplant. 21:22-28.

2015 and earlier

Song EY, S Han, B Yang, GP Morris, and JD Bui. 2015. Effect of cell density and HLA-DR incompatibility on T-cell proliferation and Forkhead box P3 expression in human mixed lymphocyte reaction. Transplant. Proc. 47:763-769.

Kong YM, NK Brown, GP Morris, and JC Flynn. 2015. The essential role of circulating thyroglobulin in maintaining dominance of natural regulatory T cell function to prevent autoimmune thyroiditis. Horm. Metab. Res. 47:711-720.

Jama B, and GP Morris. 2014. Generation of human alloantigen-specific T cells from peripheral blood. J. Vis. Exp. e52257.

Ni PP, B Solomon, CS Hsieh, PM Allen, and GP Morris. 2014. The ability to rearrange dual TCRs enhances positive selection, leading to increased allo- and autoreactive T cell repertoires. J. Immunol. 193:1778-1786.

Morris GP, GL Uy, DL Donermeyer, JF DiPersio, and PM Allen. 2013. Dual TCR T cells mediate pathologic alloreactivity in patients with acute graft versus host disease. Sci. Transl. Med. 5:188ra74.

Jackups R Jr, C Canter, SC Sweet, T Mohanakumar, and GP Morris. 2013. Changes in concentration of donor-specific antibodies to HLA predict clinical response to plasmapheresis for antibody-mediated heart and lung transplant rejection. J. Clin. Apheresis. 28:301-308.

GP Morris and PM Allen. 2012. How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat. Immunol. 13:121-128. 

Liu C, L Wetter, S Pang, DL Phelan, T Mohanakumar, and GP Morris. 2012. Cutoff Values and Data Handling for Solid-Phase Testing for Antibodies to HLA: Effects on Listing Unacceptable Antigens for Thoracic Organ Transplantation. Human Immunol 73:597-604. 

GP Morris, PP Ni, and PM Allen. 2011. Alloreactivity is limited by the endogenous peptide repertoire. Proc. Natl. Acad. Sci. U.S.A. 108:3695-3700.

Kong YC, NK Brown, JC Flynn, DJ McCormick, V Brusic, GP Morris, and CS David. 2011. Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. J. Autoimmun. 37:63-70. 
Lawrence KL, PH White, GP Morris, J Jennenmann, DL Phelan, RS Hotchkiss, and MH Kollef. 2010. CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study. Critical Care. 14:R110. 

GP Morris, DL Phelan, MD Jendrisak, and T Mohanakumar. 2010. Virtual crossmatch by identification of donor-specific anti-HLA antibodies by solid phase immunoassay a 30-month analysis in living donor kidney transplantation. Human Immunol. 71:268-273. 

GP Morris, and PM Allen. 2009. Cutting Edge: Highly alloreactive dual TCR expressing T cells play a dominant role in graft versus host disease. J. Immunol. 182:6639-6643. 

Kong YC, GP Morris, NK Brown, Y Yan, JC Flynn, and CS David. 2009. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J. Autoimmun. 33:239-246. 

GP Morris, NK Brown, and YM Kong. 2009. Naturally-existing CD4+CD25+Foxp3+ regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J. Autoimmun. 33:68-76. 

GP Morris and YM Kong. 2006. Tolerance to autoimmune thyroiditis: CD4+CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction. Frontiers in Biosi. 11:1234-1243. 

GP Morris, and YM Kong. 2006. Interference with CD4+CD25+ T cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J. Autoimmun. 26:24-31. 

Kong YM, GP Morris, and CS David. 2005. Extent of regulatory T cell influence on major histocompatibility complex class II gene control of susceptibility in murine autoimmune thyroiditis. p 197-208. In: M Zouali, Ed. Molecular Autoimmunity. Springer, New York. 

GP Morris, Y Yan, CS David, and YM Kong. 2005. H2A- and H2E- derived CD4-CD25- regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J. Immunol. 174:3111-3116. 

Wei W-Z, GP Morris, and YM Kong. 2004. Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells.  Cancer Immunol. Immunotherapy 53:73-78. 

GP Morris, L Chen, and YM Kong. 2003. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol. 226:20-29.